#171: The Gut-Brain Axis in Multiple Sclerosis. Interview with Prof. Dr. Anne-Katrin Pröbstel
In this interview, Prof. Dr. Anne-Katrin Pröbstel explains the gut–brain axis in multiple sclerosis and why the interaction between gut microbiome, immune system and nervous system is so important for MS research. She also discusses B cells, IgA, diet, vitamin D and why many findings are still part of basic research.
#169: Multiple Sclerosis in Nepal. Diagnosis, Treatment and Access to Care
Multiple Sclerosis in Nepal is still often overlooked, diagnosed late, and difficult to treat because access to MRI, neurologists, and affordable medication remains limited for many people. In this interview, Dr. Ayush Chandra and Dr. Avinash Chandra share how geography, costs, awareness, and advocacy shape MS care in Nepal — and why hope, education, and […]
#168: From Fragmented Care to Connected Care. The MS360° Approach with Dr. Isabel Voigt
In this interview, Dr. Isabel Voigt explains how the MS360° approach could help transform multiple sclerosis care. By combining digital monitoring, telemedicine, real-world data, and in-person visits, the model aims to detect changes earlier, improve communication, and support more personalized MS treatment.
#163: CAR-T Cell Therapy for MS: Hype, Hope, or Future Standard? – A Global Research Update with Prof. Barbara Willekens
CAR-T cell therapy is one of the most promising yet complex developments in multiple sclerosis research. In this in-depth interview, Professor Barbara Willekens explains how the therapy works, who might benefit, and what we know so far about its risks and potential. A scientifically grounded look at a treatment that could reshape the future of MS care.
#159: Multiple Sclerosis in Saudi Arabia. Care, Treatment, Research, and Public Awareness
How is multiple sclerosis managed in Saudi Arabia today? In this episode, neurologist Dr. Yasser Alamri shares insights on treatment access, research, and patient support. Discover how awareness and care are evolving—and why early treatment makes a difference.
#155: Genetic subtypes in MS. What they mean for your progression and treatment with Dr. Karim Kreft
Genetic subtypes in MS may help explain why the disease progresses differently from person to person. In this interview, Dr. Karim Kreft shares how genetic clustering could one day support more personalized treatment decisions. While clinical use is still in the future, the direction toward biologically guided MS care is clear.
#153: How Exercise Boosts Your Immune System: What People with MS Should Know with David Walzik
How does exercise influence the immune system in multiple sclerosis? In this interview, David Walzik explains new findings from exercise immunology, why exercise intensity matters, and how people with MS can benefit from sustainable, realistic movement — even when it’s challenging.
#152: EUPATI: Empowering Patient Voices in Medical Research and Innovation with Dr. Ingrid Klingmann
How can patients actively contribute to medical research and innovation? In this episode, Dr. Ingrid Klingmann explains how EUPATI empowers patients with knowledge, confidence, and a strong voice in clinical research.
#149: What Your Mouth Reveals About MS. Prof. Dr. Ashutosh Mangalam on the Oral Microbiome and Future Therapies
n this interview, Professor Dr. Ashutosh Mangalam explains how the oral microbiome may play a role in multiple sclerosis. We discuss key research findings, saliva-based biomarkers, oral health, and what microbiome science could mean for future MS care.
#143: How menopause impacts MS. Hormones, biomarkers, and what women need to know with Dr. Riley Bove
Menopause and MS often collide in midlife – and their symptoms can be hard to untangle. In this episode, Dr. Riley Bove explains how hormonal changes affect MS, what biomarkers reveal about brain aging and when hormone therapy may help. She also shares practical advice and lifestyle strategies so women with MS don’t have to navigate this phase alone.
